The FTSE 100 ended a difficult week firmly in negative territory on Friday, dragged lower by surging oil prices and growing unease over artificial intelligence investment returns. The blue-chip index closed down
Law firm website conversions remain one of the most critical components of a successful digital marketing strategy in today’s competitive legal landscape. Many potential clients who discover a law firm through online
More
Diageo (LSE: DGE) shares have staged a remarkable short-term recovery, rising 15% in a single month against a FTSE 100 index gain of just over 2%. The surge has given long-suffering shareholders
More
The FTSE 100 closed lower despite encouraging earnings results from advertising giant WPP and drinks conglomerate Diageo (DEO). WPP (WPP), the world’s largest advertising group, posted results that analysts broadly described as
More
Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist 2 mg/1 mL due to a label mix-up. The recall centres on
More
The 21st Century ROAD to Housing Act became Public Law 119-101 on July 11, 2026, taking effect without the President’s signature after the ten-day period under Article I, Section 7 elapsed. The
More
New Mexico Attorney General Raúl Torrez has filed a federal lawsuit against Acting Attorney General Todd Blanche and the U.S. Department of Justice over withheld Epstein investigative files. The lawsuit, filed Wednesday,
More
UK equities posted modest gains on Friday as surging oil prices boosted energy stocks and Lloyds data pointed to renewed pressure on mortgage borrowers. By 07:30 GMT, the FTSE 100 (LSE:JD.) had
More
Bark Inc. (NYSE: BARK), the dog-focused consumer products company, has reported second-quarter CY2026 sales figures that surpassed analyst estimates, sending shares sharply higher. The revenue beat caught the attention of investors who
More
Takeda has secured FDA approval for Orzeyful, a twice-daily tablet treating narcolepsy type 1 in adults, making it the first medicine of its kind. Unlike existing narcolepsy treatments that address symptoms, Orzeyful
More
Mark Paoletta became Acting Director of the Consumer Financial Protection Bureau on August 1, 2026, succeeding Russell Vought in the role. Vought’s tenure as Acting Director came to an end not through
More